Download FREE Report Sample
Download Free sampleTegafur is effective for gastric, colon, rectal, pancreatic and other digestive cancers, as well as for breast and liver cancers.
Tegafur Market contains market size and forecasts of Tegafur (Futraful) in Global, including the following market information:
Global Tegafur (Futraful) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Tegafur (Futraful) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tegafur (Futraful) include Novartis, Lilly, Pfizer, Ferring, Johnson & Johnson, Jiangsu Hengrui Pharmaceutical, HISUN, Shenzhen Wanle Pharmaceutical and Hutchison, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tegafur (Futraful) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tegafur (Futraful) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Tegafur (Futraful) Market Segment Percentages, by Type, 2021 (%)
Injection
Tablets
Capsule
Suppository
Global Tegafur (Futraful) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Tegafur (Futraful) Market Segment Percentages, by Application, 2021 (%)
Antimetabolic Use
Hormone
Cancer Drugs
Antibiotic Medicine
Target Small Molecule Drugs
Global Tegafur (Futraful) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Tegafur (Futraful) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tegafur (Futraful) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Tegafur (Futraful) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Lilly
Pfizer
Ferring
Johnson & Johnson
Jiangsu Hengrui Pharmaceutical
HISUN
Shenzhen Wanle Pharmaceutical
Hutchison
Jinghua Pharmaceutical
Yaodu Pharmaceutical
Harbin Laibotong Pharmaceutical
Shandong Xinshi Pharmaceutical
Hangzhou Zhongmei Huadong Pharmaceutical
ZHENGDA Tianqing Pharmaceutical Group
Jiangsu Aosaikang Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Lianyungang Jierui Pharmaceutical
Qilu Pharmaceutical
Beida Pharmaceutical
Qingdao Jinfeng Pharmaceutical
Tianjin Jinyao Pharmaceutical
Shanghai Kaimao Biopharmaceutical
Nanjing Xiansheng Dongyuan Pharmaceutical
Nanjing Pharmaceutical
Sichuan Huiyu Pharmaceutical
Sinopharm
Shanxi Zhendong Taisheng Pharmaceutical
Dezhou Pharmaceutical
Fresenius
Taiho
Nordic Group
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy